Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin (Q34871780)

5 August 2017

3 references

8 February 2021

3 October 2022

7 February 2024

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin (English)

1 reference

apoptosis regulatory proteins

5 August 2017

1 reference

inhibitor of apoptosis proteins

28 September 2019

1 reference

20 November 2019

1 reference

20 December 2020

1 reference

8 February 2021

Baculoviral IAP repeat containing 5

1 reference

inferred from abstract

author name string

Ronan J Kelly

1

1 reference

5 August 2017

Ariel Lopez-Chavez

2

1 reference

5 August 2017

Deborah Citrin

3

1 reference

5 August 2017

John E Janik

4

1 reference

5 August 2017

John C Morris

5

1 reference

5 August 2017

language of work or name

1 reference

6 April 2011

8 references

5 August 2017

3 April 2019

28 September 2019

20 November 2019

20 December 2020

8 February 2021

3 October 2022

7 February 2024

8 references

5 August 2017

3 April 2019

28 September 2019

20 November 2019

20 December 2020

8 February 2021

3 October 2022

7 February 2024

10

1 reference

5 August 2017

35

1 reference

Creative Commons Attribution 2.0 Generic

5 August 2017

7 references

3 April 2019

28 September 2019

20 November 2019

20 December 2020

8 February 2021

3 October 2022

on focus list of Wikimedia project

7 February 2024

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1476-4598-10-35

0 references

cites work

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Chemically synthesized human survivin does not inhibit caspase-3.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Terameprocol, a novel site-specific transcription inhibitor with anticancer activity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Hsp60 regulation of tumor cell apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

The inhibitors of apoptosis (IAPs) as cancer targets

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Targeting survivin in cancer therapy: fulfilled promises and open questions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

The case for Survivin as mitotic regulator

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Rational design of shepherdin, a novel anticancer agent.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Cell division and cell survival in the absence of survivin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Pathways of apoptotic and non-apoptotic death in tumour cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

An IAP-IAP complex inhibits apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin as a therapeutic target for radiation sensitization in lung cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin, versatile modulation of cell division and apoptosis in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Regulation of survivin function by Hsp90

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

HBXIP functions as a cofactor of survivin in apoptosis suppression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

A p34(cdc2) survival checkpoint in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Increased expression of survivin in gastric cancer patients and in first degree relatives

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin--a universal tumor antigen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Life-or-death decisions by the Bcl-2 protein family.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Transcriptional analysis of human survivin gene expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Control of apoptosis and mitotic spindle checkpoint by survivin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin, cancer networks and pathway-directed drug discovery.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Structural basis for phosphoserine-proline recognition by group IV WW domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

The chromosomal passenger complex: one for all and all for one.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Inhibition of TNF-induced apoptosis by NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin and molecular pathogenesis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin expression in primary malignant melanoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of PLK1 and survivin in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Phi29 pRNA vector for efficient escort of hammerhead ribozyme targeting survivin in multiple cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Expression of the antiapoptosis gene survivin in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-35

Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin as a radioresistance factor in pancreatic cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3083377

Survivin does not inhibit caspase-3 activity

26 October 2018

1 reference

12 December 2020

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

1 reference

12 December 2020

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin

1 reference

12 December 2020

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

1 reference

12 December 2020

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

1 reference

12 December 2020

Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor

1 reference

12 December 2020

Survivin is an independent prognostic marker for risk stratification of breast cancer patients

1 reference

12 December 2020

High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer

1 reference

12 December 2020

Regulation of survivin expression by IGF-1/mTOR signaling

1 reference

12 December 2020

Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors

1 reference

12 December 2020

Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

1 reference

12 December 2020

Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines

1 reference

12 December 2020

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

12 December 2020

Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin–cyclin B link

1 reference

12 December 2020

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

1 reference

12 December 2020

Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions

1 reference

12 December 2020

Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas

1 reference

12 December 2020

Survivin mRNA expression in patients with breast cancer

1 reference

12 December 2020

Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma

1 reference

12 December 2020

Expression of survivin and its relationship to loss of apoptosis in breast carcinomas

1 reference

12 December 2020

Nuclear expression of the antiapoptotic protein survivin in malignant melanoma

1 reference

12 December 2020

Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes

1 reference

12 December 2020

1 reference

12 December 2020

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1476-4598-10-35

1 reference

Dimensions Publication ID

5 August 2017

1025944626

0 references

Fatcat ID

release_ecfqjwpsf5fdzcszkf4xi33zka

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ecfqjwpsf5fdzcszkf4xi33zka

24 November 2022

mapped directly with Wikidata item

PMCID

3083377

1 reference

5 August 2017

1 reference